Published in
American Association for the Advancement of Science, Science Translational Medicine, 612(13), 2021
DOI: 10.1126/scitranslmed.abh2624
Links
Tools
Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19
Journal article published in 2021 by
Monique G. P. van der Wijst 
,
Sara E. Vazquez,
George C. Hartoularos,
Paul Bastard,
Tianna Grant,
Raymund Bueno ,
on behalf of the U. C. S. F. C. O. M. E. T. Consortium,
David S. Lee ,
John R. Greenland,
Deanna S. Lee,
Yang Sun ,
Yumiko Abe-Jones,
Richard Perez,
Bonny Alvarenga,
Anton Ogorodnikov
and other authors.
,
Sara E. Vazquez,
George C. Hartoularos,
Paul Bastard,
Tianna Grant,
Raymund Bueno ,
on behalf of the U. C. S. F. C. O. M. E. T. Consortium,
David S. Lee ,
John R. Greenland,
Deanna S. Lee,
Yang Sun ,
Yumiko Abe-Jones,
Richard Perez,
Bonny Alvarenga,
Anton Ogorodnikov
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
Type I interferon autoantibodies in patients with COVID-19 are associated with poor interferon responses and increased LAIR1 abundance in leukocytes.